Murthy M S, Calleman C J, Osterman-Golkar S, Segerbäck D, Svensson K
Mutat Res. 1984 Jun;127(1):1-8. doi: 10.1016/0027-5107(84)90133-7.
Ethylation of guanine-N-7 in the DNA of liver and kidney and of nucleophilic groups in hemoglobin has been studied as a measure of the in vivo dose in the mouse after i.p. administration of radiolabeled ethyl methanesulfonate (EMS). The degree of ethylation in both hemoglobin and DNA of the studied tissues was found to increase proportionally to the injected amount in the range 0.32-100 mumoles EMS/kg b.w. Above this range a somewhat higher than proportional degree of ethylation was found, indicating saturation of a system for detoxification of the compound, resulting in a decreased rate of elimination and consequently an increased dose in the tissues of this directly alkylating agent. The ratio between covalent binding to DNA and to hemoglobin, however, was approximately constant over the wide range of doses studied. For biological effects with a linear dose-response relationship, this demonstrates the validity of hemoglobin alkylation as an indicator of the risk.
研究了经腹腔注射放射性标记的甲磺酸乙酯(EMS)后,小鼠肝脏和肾脏DNA中鸟嘌呤 - N - 7的乙基化以及血红蛋白中亲核基团的乙基化,以此作为体内剂量的一种衡量指标。在所研究的组织中,血红蛋白和DNA的乙基化程度在0.32 - 100微摩尔EMS/千克体重的范围内与注射量成比例增加。高于此范围时,发现乙基化程度略高于比例增加,这表明该化合物解毒系统饱和,导致消除速率降低,进而使这种直接烷基化剂在组织中的剂量增加。然而,在所研究的广泛剂量范围内,与DNA和血红蛋白的共价结合比率大致恒定。对于具有线性剂量 - 反应关系的生物学效应,这证明了血红蛋白烷基化作为风险指标的有效性。